ArticleMolecular biomedicine2026
The m
Hehua Ma, Yuxin Hong, Zhi Xu, Zuyi Weng, Yuanxun Yang, Wei Song, Juan Li
Abstract read
In one paragraphArticle in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Hehua MaPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Yuxin HongPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Zhi XuPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Zuyi WengPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Yuanxun YangPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Wei SongPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. songwei3929@163.com.ORCID http://orcid.org/0000-0003-3756-198X Juan LiPhase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. juanli2003@163.com.
Funding
Anhui Province Key Laboratory of Translational Cancer Research KFDX202201Nanjing Health Technology Development Project YKK24079National Natural Science Foundation of China 31371399National Natural Science Foundation of China 82002984Natural Science Foundation of Jiangsu Province BK20200119Open Project of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment KFKT202506
6 · The paper itselfAbstract
Indexed as
AdenosineCarcinoma, HepatocellularLiver NeoplasmsRNA-Binding ProteinsTranscription Factor RelBAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMice, NudeAdenosineIGF2BP2 protein, humanNF-kappa BN-methyladenosineRELB protein, humanRNA-Binding ProteinsTranscription Factor RelBHepatocellular carcinomaIGF2BP2NF-κBRELBRNA stability
Identifiers
PMID42096134
PMCPMC13153289
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390